New research sheds light on cancer of the appendix
Researchers at Wake Forest Baptist Medical Center have demonstrated that cancer of the appendix is different than colon cancer, a distinction that could lead to more effective treatments for both diseases.
Cancer
Mar 07, 2012 |
5 / 5 (1) |
0
The challenges of cancer vaccines
The first therapeutic cancer vaccine has now been approved by the FDA, and a diverse range of therapeutic cancer vaccines directed against a spectrum of tumor-associated antigens are currently being evaluated in clinical ...
Cancer
Mar 06, 2012 |
5 / 5 (1) |
0
Web-based support helps women with breast cancer
Every day 18 Swedish women are diagnosed with breast cancer. Although there is a real need for support and information, many women struggle and get lost in the deluge of information. In a study of 227 women, researchers at ...
Cancer
Mar 05, 2012 |
not rated yet |
0
Complementary meds used by 17 percent of elderly with cancer
(HealthDay) -- The prevalence of older people with cancer using complementary medications as they start a chemotherapy regimen is 17 percent, and is associated with less advanced disease and higher functional ...
Cancer
Mar 02, 2012 |
not rated yet |
0
Molecule's role in cancer suggests new combination therapy
Researchers at the University of Illinois at Chicago College of Medicine have found that a molecule found at elevated levels in cancer cells seems to protect them from the "cell-suicide" that is usually triggered by chemotherapy ...
Cancer
Mar 01, 2012 |
5 / 5 (2) |
0
|
Ototoxicity rates in children receiving carboplatin studied
(HealthDay) -- Retinoblastoma patients who are younger than 6 months of age at the start of carboplatin treatment experience a higher incidence of ototoxicity, according to a study published online Feb. 27 ...
Cancer
Feb 29, 2012 |
not rated yet |
0
Radiation treatment transforms breast cancer cells into cancer stem cells
Breast cancer stem cells are thought to be the sole source of tumor recurrence and are known to be resistant to radiation therapy and don't respond well to chemotherapy.
Cancer
Feb 13, 2012 |
not rated yet |
0
Surgery and chemotherapy are possible for pregnant women with breast cancer
Breast cancer in pregnant women is as common as in non-pregnant women of the same age, with no evidence to suggest pregnancy increases the risk of such cancer. In the majority of cases, pregnant women can have their breast ...
Surgery
Feb 09, 2012 |
not rated yet |
0
Cancer drugs shown to cause mutations in mice offspring
(Medical Xpress) -- For many years, most of the studies done to see what effects cancer treatment has on the offspring of survivors, has involved radiation. This is because radiation is known to cause mutations in cells. ...
Medical research
Jan 31, 2012 |
4 / 5 (2) |
0
|
Oral temperature changes in head and neck cancer patients predicts side effect severity
Slight temperature increases of the oral mucus membranes early in a head and neck cancer patient's chemotherapy and radiation therapy (chemoradiotherapy) treatment is a predictor of severe mucositis later in treatment, according ...
Cancer
Jan 26, 2012 |
not rated yet |
0
Childhood cancer survivors' exposure to chemotherapy, radiation does not increase risk of birth defects in their childre
A large, retrospective study shows that children of childhood cancer survivors who received prior treatment involving radiation to testes or ovaries and/or chemotherapy with alkylating agents do not have an increased risk ...
Cancer
Dec 12, 2011 |
not rated yet |
0
Study of two sisters sheds light on lymphoma evolution
When a 41-year-old woman was diagnosed with chronic-phase chronic myeloid leukemia, she received a bone marrow transplant and subsequent leukocyte infusion from her sister. These treatments controlled her leukemia, but seven ...
Cancer
Dec 12, 2011 |
not rated yet |
0
Researchers find drug duo kills chemotherapy-resistant ovarian cancer cells
The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida. ...
Cancer
Dec 07, 2011 |
not rated yet |
0
Patient receives first prescription for FDA-approved brain tumor treatment
(Medical Xpress) -- The University of Illinois Hospital is the first center in North America to prescribe a new FDA-approved treatment for patients with the most common and aggressive type of brain tumor, glioblastoma multiforme, ...
Cancer
Dec 05, 2011 |
not rated yet |
0
More intensive chemotherapy dramatically improves recurrence, survival in younger patients with aggressive lymphoma
Younger patients with diffuse large B-cell lymphoma given a more intensive regimen of chemotherapy combined with rituximab survive significantly longer, and are approximately twice as likely to remain in remission 3 years ...
Cancer
Nov 24, 2011 |
not rated yet |
0
